- E-mailhelene.bustad.johannessen@uib.no
- Visitor AddressInstitutt for Biomedisin, Jonas Lies vei 91BergenRoom5A113B
- Postal AddressPostboks 78045020 Bergen
- Bustad, HJ. et al., Conformational stability and activity analysis of two hydroxymethylbilane synthase mutants, K132N and V215E, with different phenotypic association with acute intermittent porphyria. Biosci. Rep. 2013;33(4):e00056
- Bustad, HJ, Skjaerven, L. et al., The Peripheral Binding of 14-3-3γ to Membranes Involves Isoform-Specific Histidine Residues. PLoS One. 2012;7(11):e49671
- Bustad, HJ. et al., The binding of 14-3-3γ to membranes studied by intrinsic fluorescence spectroscopy. FEBS Lett, 2011. 585(8): p. 1163-1168.
- Steinkopf, S. et al., pH-dependent interaction of psychotropic drug with glycerophospholipid monolayers studied by the Langmuir technique. Biophys Chem, 2010. 152(1-3): p. 65-73.
Academic article
- (2022). High-affinity anti-Arc nanobodies provide tools for structural and functional studies. PLOS ONE. 33 pages.
- (2022). Characterisation of a common hotspot variant in acute intermittent porphyria sheds light on the mechanism of hydroxymethylbilane synthase function. FEBS Open Bio. 2136-2146.
- (2021). Genetic Dominant Variants in STUB1, Segregating in Families with SCA48, Display In Vitro Functional Impairments Indistinctive from Recessive Variants Associated with SCAR16. International Journal of Molecular Sciences.
- (2021). Characterization of porphobilinogen deaminase mutants reveals that arginine-173 is crucial for polypyrrole elongation mechanism. iScience.
- (2020). Arc self‐association and formation of virus‐like capsids are mediated by an N‐terminal helical coil motif. The FEBS Journal.
- (2019). A Pharmacological Chaperone Therapy for Acute Intermittent Porphyria. Molecular Therapy.
- (2017). In vitro characterization of six STUB1 variants in spinocerebellar ataxia 16 reveals altered structural properties for the encoded CHIP proteins. Bioscience Reports. 1-12.
- (2015). Arc is a flexible modular protein capable of reversible self-oligomerization. Biochemical Journal. 145-158.
- (2013). Conformational stability and activity analysis of two hydroxymethylbilane synthase mutants, K132N and V215E, with different phenotypic association with acute intermittent porphyria. Bioscience Reports. 617-U203.
- (2012). The peripheral binding of 14-3-3gamma to membranes involves isoform-specific histidine residues. PLOS ONE.
- (2011). The binding of 14-3-3 gamma to membranes studied by intrinsic fluorescence spectroscopy. FEBS Letters. 1163-1168.
Feature article
- (2020). Norsk fagspråk må styrkes. Klassekampen.
- (2017). Det er hardt å være forskar! Bioingeniøren. 28-29.
Abstract
- (2013). Searching for pharmacological chaperones aiding to stabilize hydroxymethylbilane synthase. The FEBS Journal. 298-298.
- (2010). Characterization of the molecular basis of acute intermittent porphyria. The FEBS Journal. 76-76.
- (2010). CHARACTERIZATION OF THE MOLECULAR BASIS OF ACUTE INTERMITTENT PORPHYRIA. The Journal of Inherited Metabolic Disease (JIMD). S177-S177.
- (2007). pH-dependent drug interaction with glycerophospholipid monolayers studied by the Langmuir technique. Chemistry and Physics of Lipids. S31-S32.
Academic literature review
- (2021). Acute intermittent porphyria: An overview of therapy developments and future perspectives focusing on stabilisation of HMBS and proteostasis regulators. International Journal of Molecular Sciences. 25 pages.
More information in national current research information system (CRIStin)